A Comparison of Daunorubicin/Ara-C Versus Daunorubicin/Clofarabine As Induction Treatment in Older Patients with Aml and High Risk Mds: Long Term Results of the Uk Ncri Aml16 Trial in 806 Patients
Russell, N Burnett, A Kjeldsen, L Milligan, D Cahalin, P Kell, J Dennis, Michael Hills, R
Russell, N
Burnett, A
Kjeldsen, L
Milligan, D
Cahalin, P
Kell, J
Dennis, Michael
Hills, R
Citations
Altmetric:
Abstract
Description
Date
2015
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
A Comparison of Daunorubicin/Ara-C Versus Daunorubicin/Clofarabine As Induction Treatment in Older Patients with Aml and High Risk Mds: Long Term Results of the Uk Ncri Aml16 Trial in 806 Patients. 2015, 100 194 Haematologica